Reed McClung

Reed joined Eagle with more than 30 years of commercial experience and 25 years of pharmaceutical leadership across multiple commercial functions. His oncology/hematology experience spans 16+ years with Novartis, Celgene, and Bristol-Myers Squibb (BMS). Prior to joining Eagle, Reed led the $12B multiple myeloma franchise at Celgene/BMS. Prior to Celgene, Reed spent 13 years at Novartis in positions of increasing responsibility in both Canada and the U.S.
Reed earned his B.S. in biology from Mount Allison University, NB, Canada.